# Drug Topics

> Drug Topics - Healthcare Publication

- Base URL: https://www.drugtopics.com
- Generated: 2026-10-21T00:24:16.249Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.drugtopics.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.drugtopics.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.drugtopics.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.drugtopics.com/robots.txt](https://www.drugtopics.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [American Pharmacists Month](https://www.drugtopics.com/american-pharmacists-month)
- [Associations News](https://www.drugtopics.com/associations)
- [Clinical](https://www.drugtopics.com/clinical)
- [Clinical News](https://www.drugtopics.com/clinical-news)
- [Conferences](https://www.drugtopics.com/conferences)
- [Expert Interviews](https://www.drugtopics.com/expert-interviews)
- [FDA Updates](https://www.drugtopics.com/fda-updates)
- [KCast](https://www.drugtopics.com/k-cast)
- [Law and Advocacy](https://www.drugtopics.com/legal-news)
- [Media](https://www.drugtopics.com/media)
- [News](https://www.drugtopics.com/news)
- [Pharmacy Law and Regulations ](https://www.drugtopics.com/pharmacy-law-and-regulations)
- [Podcasts](https://www.drugtopics.com/podcasts)
- [Practice Management](https://www.drugtopics.com/practice-management)
- [Practice Type](https://www.drugtopics.com/practice-type)
- [Provider Toolkit](https://www.drugtopics.com/provider-toolkit)
- [Publications](https://www.drugtopics.com/publications)
- [Script-Ed](https://www.drugtopics.com/script-ed)
- [Sponsored Resources](https://www.drugtopics.com/sponsored-resources)
- [Technology Trends](https://www.drugtopics.com/technology)
- [Total Pharmacy](https://www.drugtopics.com/total-pharmacy)
- [Treatment Areas](https://www.drugtopics.com/treatment-areas)
- [Video Series](https://www.drugtopics.com/video-series)
- [Videos](https://www.drugtopics.com/videos)
- [Viewpoints](https://www.drugtopics.com/viewpoints)
- [White Board Video](https://www.drugtopics.com/white-board-video)

## Featured Content

- [FDA Approves First Generic for Climara Pro Hormone Therapy Patch](https://www.drugtopics.com/view/fda-approves-first-generic-for-climara-pro-hormone-therapy-patch): With safety and efficacy profiles aligning with its brand-name formulation, this new patch could be key for women struggling with hormone therapy adhe...
- [Harms of Public Health Measures Overlooked in COVID-19 Policy Reviews](https://www.drugtopics.com/view/harms-of-public-health-measures-overlooked-in-covid-19-policy-reviews): Investigators link oversight with eroding trust in health authorities and call on future pandemic inquiries to weigh trade-offs.
- [American Pharmacists Month: How Technology Breeds Sustainable Pharmacy Practice](https://www.drugtopics.com/view/how-technology-breeds-sustainable-pharmacy-practice): Lara Zakaria, PharmD, MS, CNS, FMCP, illustrates the breadth of health technology going in and out of community pharmacy practice.
- [Trutakna Reduces Proteinuria in Adults With Primary IgAN](https://www.drugtopics.com/view/trutakna-reduces-proteinuria-in-adults-with-primary-igan): Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
- [PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026](https://www.drugtopics.com/view/pbm-network-terminations-bring-risks-beyond-lost-contracts-ncpa-2026): Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
- [Pharmacists Step Up on Test-To-Treat This American Pharmacist Month](https://www.drugtopics.com/view/pharmacists-step-up-on-test-to-treat-this-american-pharmacist-month): Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
- [PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026](https://www.drugtopics.com/view/pbm-underpayment-persists-as-cost-plus-brings-new-strain-ncpa-2026): AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 20...
- [FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026](https://www.drugtopics.com/view/scaling-pharmacy-services-through-glp-1-care-ncpa-2026): Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
- [Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026](https://www.drugtopics.com/view/pharmacists-must-guide-peptide-talks-pending-fda-action-ncpa-2026): Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
- [FDA Approves Brytly for OTC Eye Redness Relief](https://www.drugtopics.com/view/fda-approves-brytly-for-otc-eye-redness-relief): This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.

## Feeds and Indexes

- [RSS Feed](https://www.drugtopics.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.drugtopics.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.drugtopics.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.drugtopics.com/authors): Browse all contributors and their published work